Neuronal intranuclear inclusion disease (NIID) is
Neuronal intranuclear inclusion disease (NIID), also known as neuronal intranuclear hyaline inclusion disease, or intranuclear inclusion body disease, is a progressive and fatal neurodegenerative disease [1] [2] [3] 5 . NIID presents with neuronal and glial intranuclear inclusions widespread through the central and peripheral neuronal system. These inclusions are eosinophilic on hematoxyline and eosin staining, and immunoreactive to anti-ubiquitin and anti-p62 antibodies 8 . Ultrastructural examination showed that the intranuclear inclusions were well circumscribed masses without a separating membrane composed with mesh of fine straight filaments arranged haphazardly and occasionally with dense core 3, 6, 13 . However, neuronal loss is relatively localized in each case, and the extent of neuronal loss is supposed to correlate with the clinical manifestation. Clinical manifestations of NIID are highly variable, and can include pyramidal and extrapyramidal symptoms 14, 15 , cerebellar ataxia 16, 17 , dementia or mental retardation 1, 4 , convulsion 14 , peripheral neuropathy 7 , and autonomic dysfunction 2, 7 . This wide range of clinical phenotypes made antemortem diagnosis of NIID difficult for a long time. However, by skin biopsy, we have been able to diagnose many NIID cases 11 . Here we describe a genetic alteration consistently found in NOTCH2NLC for familial and sporadic NIID cases.
We examined NIID patients from 9 families (Fig. 1 (Fig. 3a) .
We could not identify any pathogenic SNPs or CNVs in WGS or WES data (data not shown).
Then we performed long read WGS either with PacBio RSII or PromethION on 13 affected and 4 unaffected members from 8 families, and checked tandem repeat copy number changes genome-wide using tandem-genotypes Table 1 ), using the tandem-genotypes prioritization tool 22 .
In the reference human genome (hg38), this repeat sequence is (GGC) 9 (GGA) 2 (GGC) 2 . It is possible that expanded repeats contain GGA in addition to GGC. Expanded repeat sequences were extracted and multiple-alignment was done using MAFFT ( Supplementary Fig. 2 ) 23 . Due to nanopore's high tendency of errors in homopolymers and adenine/guanine substitutions, it is difficult to obtain accurate multiple alignment and consensus sequence of expanded repeats.
However, it is possible that (GGA)n is also present in the expanded repeat towards the 3' end in the patients from families 1, 2 and 3, because reads from both DNA strands support GGA, and also PacBio reads in one individual (F1-6) have GGA ( Supplementary Fig. 2, asterisk) . Table 3) . We also checked the repeat expansion in 39 sporadic NIID patients. Surprisingly, all the sporadic patients had the expansion (Supplementary Table 4 ). Taken together, (GGC)n repeat expansion in NOTCH2NLC was consistently found in both familial NIID patients and sporadic NIID patients diagnosed by skin biopsy.
It is not clear whether expanded GGC repeats become highly methylated, which might possibly repress NOTCH2NLC transcripts from the expansion allele. NOTCH2NLC is one of the three human-specific NOTCH2-related genes (NOTCH2NLA, NOTCH2NLB and NOTCH2NLC) in 1q21.1, highly expressed in various radial glia populations including outer radial glia, astrocytes and microglia, and thought to be involved in the evolutionary expansion of the human cortex 24, 25 .
The NOTCH2NL genes have >99.1% sequence identity to the N-terminal portion of NOTCH2, but NOTCH2NLC contains a 2 bp deletion just downstream of the NOTCH2 start codon and lacks the N-terminal signal peptide. Ectopic expression of NOTCH2NL delays cortical neuron differentiation in mouse, and deletion of NOTCH2NL affects human cortical organoid development 24 . The onset ages of NIID patients in this study are after 20 years, no patients showed structural brain abnormalities such as microcephaly, and DNA methylation of NOTCH2NLC
showed no difference between GGC expanded and non-expanded alleles.
Therefore, the functional loss of NOTCH2NLC through CpG methylation due to GGC expansion may be less likely.
In this study, NIID patients showed (GGC)n expansion in the 5'UTR of NOTCH2NLC, and autopsied NIID cases consistently present with ubiquitinpositive intranuclear inclusions in both nervous system and somatic cells (when tested). The combination of triplet repeat expansion and widely observed intranuclear inclusion is similar to Fragile X-associated tremor/ataxia syndrome (FXTAS) 12, 26 . Expansion of a (GGC)n repeat to 55-200 copies in the 5'UTR of FMR1 causes FXTAS, presenting tremor, ataxia and cognitive dysfunction in the sixth decades with widely observed intranuclear inclusions both in nervous system cells and somatic cells 27, 28 . One hypothesis of the FXTAS toxicity mechanism is that repeat-bearing RNA interacts with multiple GGC RNA-binding proteins leading to their functional depletion 29 . Another hypothesis is that GGC repeats in the Fragile X RNA can be translated into toxic proteins, either by repeat-associated non-AUG (RAN) translation or the utilization of noncanonical start codons to produce expanded polypeptides, such as polyglycine 28, 30, 31 . As for NIID, both of these hypotheses may possibly be related to the pathomechanism of NIID, and we need to investigate the expression or translation of GGC expanded RNA, including the constituents of intranuclear inclusions, in the next step. Besides, in this study, families 1 and 2 showed weakness, families 4, 7, 8, 9, 10 and D showed dementia and leukoencephalopathy, and families 3 showed both weakness and dementia.
We could not recognize any difference or trend in the degree of (GGC)n expansion among these three subgroups, perhaps due to inaccuracy of long read sequencing data. Furthermore, we observed similar (GGC)n expansion in all 39 sporadic NIID patients. The clinical manifestation of these sporadic NIID patients was almost the same as the familial NIID patients with dementia, the onset age was around the sixties and head MRI showed leukoencephalopathy and abnormally high intensity DWI signal in the cortico-medullary junction 11 . Therefore, except for familial presentation, we can not practically differentiate familial and sporadic NIID. We need to study on these unsolved issues of NIID with a large NIID patient cohort diagnosed by skin biopsy and genetic alteration in NOTCH2NLC, and hopefully develop a disease modifying therapy of NIID in the near future.
The NOTCH2NL genes at 1q21.1 were not annotated as three different genes, because these regions were erroneously assembled and missed in the human reference genome, until hg38 24, 25 . These regions are highly similar, moreover (GGC)n is 100% GC-rich, which is difficult to analyze by standard sequencing methods. Long read sequencing with >10 kb reads may have a big advantage for resolving such homologous (duplicated) and repetitive regions, though its application to actual human diseases is still challenging 32 . We took advantage of using PromethION and applied it to multiple patients, and obtained X8~X25 whole genome coverage from single flowcell runs. In addition, we recently developed a computational tool, tandem-genotypes 22 , to find tandem repeats possibly causing human diseases. By utilizing this, we detected NOTCH2NLC repeat expansions in familial and sporadic NIID, even from as low as (X8) coverage data. Therefore, this study provides a stark example of long read sequencing for resolving unsolved human diseases.
To our knowledge, clear pathogenic variants have never been reported among approximately 30 human-specific genes evolutionarily generated by segmental duplications 24, 25, 33 . Thus, we believe that such human-specific genes are very important not only in human (brain) evolution but also in human neurological diseases. We anticipate that further studies will reveal additional pathogenic variations in human specific genes associated with human diseases.
In conclusion, the genetic cause of familial and sporadic NIID is finally solved. We predict that the prevalence of NIID is larger than previously thought 11 , and NIID may possibly account for a substantial part of dementia population. 
